FI942932L - Farmaseuttinen koostumus ja menetelmä sen valmistamiseksi - Google Patents

Farmaseuttinen koostumus ja menetelmä sen valmistamiseksi Download PDF

Info

Publication number: FI942932L
Authority: FI; Finland
Prior art keywords: preparation; pharmaceutical composition; pharmaceutical; composition
Prior art date: 1991-12-20

Application number

FI942932A

Other languages

English (en)

Swedish (sv)

Other versions

FI942932A0 (fi

Inventor

Kalman Magyar

Jozsef Gaaol

Istvan Sziraki

Jozsef Lengyel

Szabo Anna Z

Katalin Marmarosi

Istvan Hermecz

Istvan Szatmari

Zoltan Toeroek

Peter Koermoeczy

Original Assignee

Chinoin Gyogyszer Es Vegyeszet

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-12-20

Filing date

1994-06-17

Publication date

1994-06-17

1994-06-17 Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet

1994-06-17 Publication of FI942932A0 publication Critical patent/FI942932A0/fi

1994-06-17 Publication of FI942932L publication Critical patent/FI942932L/fi

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Psychiatry (AREA)
Epidemiology (AREA)
Hospice & Palliative Care (AREA)
Pain & Pain Management (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

FI942932A 1991-12-20 1994-06-17 Farmaseuttinen koostumus ja menetelmä sen valmistamiseksi FI942932L (fi)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
HU914060A HUT63579A (en)	1991-12-20	1991-12-20	Process for producing double-phase pharmaceutical compositions suitable for treating diseases occurring during neurodegenerative processes
PCT/HU1992/000060 WO1993012775A1 (en)	1991-12-20	1992-12-18	Pharmaceutical composition and process for the preparation thereof

Publications (2)

Publication Number	Publication Date
FI942932A0 FI942932A0 (fi)	1994-06-17
FI942932L true FI942932L (fi)	1994-06-17

Family

ID=10966728

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI942932A FI942932L (fi)	1991-12-20	1994-06-17	Farmaseuttinen koostumus ja menetelmä sen valmistamiseksi

Country Status (27)

Country	Link
US (1)	US5589513A (fi)
EP (1)	EP0617615A1 (fi)
JP (1)	JPH07502730A (fi)
KR (1)	KR940703655A (fi)
AU (1)	AU677170B2 (fi)
BG (1)	BG98827A (fi)
BR (1)	BR9206950A (fi)
CA (1)	CA2125776A1 (fi)
CZ (1)	CZ147494A3 (fi)
EC (1)	ECSP930933A (fi)
EE (1)	EE03015B1 (fi)
FI (1)	FI942932L (fi)
HU (2)	HUT63579A (fi)
IL (1)	IL104150A (fi)
LT (1)	LT3119B (fi)
LV (1)	LV10386B (fi)
MY (1)	MY111055A (fi)
NO (1)	NO942303D0 (fi)
NZ (1)	NZ246384A (fi)
PH (1)	PH31073A (fi)
PL (1)	PL172048B1 (fi)
RO (1)	RO115785B1 (fi)
RU (1)	RU2125448C1 (fi)
SI (1)	SI9200404A (fi)
SK (1)	SK74494A3 (fi)
WO (1)	WO1993012775A1 (fi)
ZA (1)	ZA929883B (fi)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5844003A (en) *	1991-04-04	1998-12-01	Innovations Foundation	Use of deprenyl compounds to maintain, prevent loss, or recover nerve cell function
US5817336A (en) *	1993-04-02	1998-10-06	Orion-Yhtyma Oy	Composition containing selegiline
DE4432610C1 (de) *	1994-09-13	1996-02-01	Knoll Ag	Verfahren zur Herstellung von Selegilin-Hydrochlorid
JPH10513455A (ja)	1995-02-10	1998-12-22	ザユニバーシティオブトロントイノベーションズファウンデーション	緑内障治療用のデプレニル化合物
JP4499208B2 (ja) *	1998-10-29	2010-07-07	株式会社フジモト・コーポレーション	新規な光学活性アミノペンタン誘導体
US7374779B2 (en) *	1999-02-26	2008-05-20	Lipocine, Inc.	Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
HUP9902482A2 (hu) *	1999-07-22	2002-04-29	Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt.	P-fluoro-selegilin alkalmazása neuroprotektív gyógyszerkészítmények előállítására
EP2053033A1 (en) *	2007-10-26	2009-04-29	Bayer Schering Pharma AG	Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumors
US11304960B2 (en)	2009-01-08	2022-04-19	Chandrashekar Giliyar	Steroidal compositions
DE102009045056A1 (de) *	2009-09-28	2011-03-31	Henkel Ag & Co. Kgaa	Fleckenvorbehandlungsmittel
US9034858B2 (en)	2010-11-30	2015-05-19	Lipocine Inc.	High-strength testosterone undecanoate compositions
US9358241B2 (en)	2010-11-30	2016-06-07	Lipocine Inc.	High-strength testosterone undecanoate compositions
US20180153904A1 (en)	2010-11-30	2018-06-07	Lipocine Inc.	High-strength testosterone undecanoate compositions
US20120148675A1 (en)	2010-12-10	2012-06-14	Basawaraj Chickmath	Testosterone undecanoate compositions
US9498485B2 (en)	2014-08-28	2016-11-22	Lipocine Inc.	Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
WO2016033549A2 (en)	2014-08-28	2016-03-03	Lipocine Inc.	(17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
CA3078723A1 (en)	2016-11-28	2018-05-31	Nachiappan Chidambaram	Oral testosterone undecanoate therapy
CA3107214A1 (en)	2018-07-20	2020-01-23	Lipocine Inc.	Liver disease

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1227447B (de) *	1962-03-30	1966-10-27	Chinoin Gyogyszer Es Vegyeszet	Verfahren zur Herstellung von Phenylisopropylaminen
HU193662B (en) *	1983-12-20	1987-11-30	Chinoin Gyogyszer Es Vegyeszet	Process for producing synergetic pharmaceutical composition of antidepressive aktivity
HU207282B (en) *	1984-05-31	1993-03-29	Chinoin Gyogyszer Es Vegyeszet	Process for producing phenyl-alkyl-amine derivatives and pharmaceutical compositions containing them
DE3764144D1 (de) *	1986-04-16	1990-09-13	Asta Pharma Ag	Synergistische kombination von amantadin und selegilin.
HU207280B (en) *	1986-09-25	1993-03-29	Chinoin Gyogyszer Es Vegyeszet	Process for producing new phenyl-alkyl-amines and pharmaceutical compositions containing them
HU197510B (en) *	1986-12-19	1989-04-28	Chinoin Gyogyszer Es Vegyeszet	Process for producing pharmaceutical composition containing phenyl-alkyl-amine derivatives, against motion-sick
US4861800A (en) *	1987-08-18	1989-08-29	Buyske Donald A	Method for administering the drug deprenyl so as to minimize the danger of side effects
GB8807504D0 (en) *	1988-03-29	1988-05-05	Sandoz Ltd	Improvements in/relating to organic compounds
HU208484B (en) *	1988-08-17	1993-11-29	Chinoin Gyogyszer Es Vegyeszet	Process for producing pharmaceutical composition containing acid additional salt of selegilin as active component for treating schisofrenia
CA2037178A1 (en) *	1990-02-28	1991-08-29	Albert Walter Brzeczko	Deprenyl/l-dopa/carbidopa pharmaceutical composition
GB9011767D0 (en) *	1990-05-25	1990-07-18	Britannia Pharmaceuticals Ltd	Pharmaceutical compositions
US5169868A (en) *	1991-03-01	1992-12-08	University Of Saskatchewan	Aliphatic propargylamines as specific mao-b inhibitors
US5444095A (en) *	1991-04-04	1995-08-22	University Of Toronto, Innovations Foundation	Use of deprenyl to rescue damaged nerve cells
HU209605B (en) *	1991-04-15	1994-09-28	Chinoin Gyogyszer Es Vegyeszet	Process for production of wather-free transdermal preparation
US5326770A (en) *	1992-07-17	1994-07-05	The Du Pont Merck Pharmaceutical Company	Monoamine oxidase-B (MAO-B) inhibitory 5-substituted 2,4-thiazolidinediones useful in treating memory disorders of mammals

1991
- 1991-12-20 HU HU914060A patent/HUT63579A/hu unknown
1992
- 1992-12-18 SK SK744-94A patent/SK74494A3/sk unknown
- 1992-12-18 SI SI9200404A patent/SI9200404A/sl unknown
- 1992-12-18 EP EP93901880A patent/EP0617615A1/en not_active Withdrawn
- 1992-12-18 CA CA002125776A patent/CA2125776A1/en not_active Abandoned
- 1992-12-18 JP JP5510411A patent/JPH07502730A/ja active Pending
- 1992-12-18 WO PCT/HU1992/000060 patent/WO1993012775A1/en not_active Application Discontinuation
- 1992-12-18 ZA ZA929883A patent/ZA929883B/xx unknown
- 1992-12-18 NZ NZ246384A patent/NZ246384A/en unknown
- 1992-12-18 IL IL104150A patent/IL104150A/xx not_active IP Right Cessation
- 1992-12-18 BR BR9206950A patent/BR9206950A/pt not_active Application Discontinuation
- 1992-12-18 KR KR1019940702143A patent/KR940703655A/ko active IP Right Grant
- 1992-12-18 RO RO94-01015A patent/RO115785B1/ro unknown
- 1992-12-18 PH PH45474A patent/PH31073A/en unknown
- 1992-12-18 US US08/256,128 patent/US5589513A/en not_active Expired - Fee Related
- 1992-12-18 CZ CZ941474A patent/CZ147494A3/cs unknown
- 1992-12-18 MY MYPI92002341A patent/MY111055A/en unknown
- 1992-12-18 AU AU32652/93A patent/AU677170B2/en not_active Ceased
- 1992-12-18 PL PL92304116A patent/PL172048B1/pl unknown
- 1992-12-18 RU RU94031161A patent/RU2125448C1/ru active
- 1992-12-20 LV LVP-92-547A patent/LV10386B/en unknown
- 1992-12-21 LT LTIP249A patent/LT3119B/lt not_active IP Right Cessation
1993
- 1993-05-25 EC EC1993000933A patent/ECSP930933A/es unknown
1994
- 1994-06-02 BG BG98827A patent/BG98827A/xx unknown
- 1994-06-17 NO NO942303A patent/NO942303D0/no unknown
- 1994-06-17 FI FI942932A patent/FI942932L/fi unknown
- 1994-08-10 EE EE9400117A patent/EE03015B1/xx unknown
1995
- 1995-06-16 HU HU95P/P00218P patent/HU211478A9/hu unknown

Also Published As

Publication number	Publication date
BG98827A (en)	1995-06-30
SK74494A3 (en)	1995-01-12
FI942932A0 (fi)	1994-06-17
JPH07502730A (ja)	1995-03-23
MY111055A (en)	1999-08-30
NZ246384A (en)	1996-02-27
LV10386B (en)	1995-12-20
WO1993012775A1 (en)	1993-07-08
AU677170B2 (en)	1997-04-17
LTIP249A (en)	1994-07-15
NO942303D0 (no)	1994-06-17
PL172048B1 (pl)	1997-07-31
LV10386A (lv)	1995-02-20
CA2125776A1 (en)	1993-07-08
EP0617615A1 (en)	1994-10-05
RU2125448C1 (ru)	1999-01-27
NO942303L (fi)	1994-08-17
LT3119B (en)	1994-12-27
US5589513A (en)	1996-12-31
HUT63579A (en)	1993-09-28
HU914060D0 (en)	1992-03-30
ECSP930933A (es)	1994-04-20
EE03015B1 (et)	1997-08-15
ZA929883B (en)	1994-05-16
KR940703655A (ko)	1994-12-12
BR9206950A (pt)	1995-11-28
HU211478A9 (en)	1995-11-28
CZ147494A3 (en)	1995-01-18
AU3265293A (en)	1993-07-28
IL104150A (en)	1997-11-20
PH31073A (en)	1998-02-05
SI9200404A (en)	1993-06-30
RO115785B1 (ro)	2000-06-30

Publication	Publication Date	Title
FI944961L (fi)	1994-10-21	Farmaseuttinen valmiste ja menetelmä sen valmistamiseksi
FI941137L (fi)	1994-09-12	2-debentsoyyli-2-asyylitaksolijohdannaisia ja menetelmiä niiden valmistamiseksi
FI951305L (fi)	1995-03-20	Lääketieteellinen materiaali ja menetelmä sen valmistamiseksi
FI101310B1 (fi)	1998-05-29	Polymeerikoostumus ja menetelmä sen valmistamiseksi
FI945476L (fi)	1995-05-24	Hitaasti vapautuvat koostumukset ja menetelmä farmaseuttisten koostumusten valmistamiseksi
FI956270L (fi)	1995-12-27	Piperdiinijohdannaisia ja menetelmä niiden valmistamiseksi
FI964028L (fi)	1996-10-08	Uusi farmaseuttinen formulaatio ja menetelmä
FI922958L (fi)	1992-12-28	Farmaceutisk sammansaettning
FI981777L (fi)	1998-08-18	Farmaseuttinen ainekoostumus
FI922316L (fi)	1992-11-24	Farmaceutisk sammansaettning
FI945198L (fi)	1994-11-04	Farmaseuttiset ja muut annosmuodot
BR1100824A (pt)	1999-08-31	Composto e composição farmacêutica
FI962445L (fi)	1996-06-12	Paroksetiinitabletteja ja menetelmä niiden valmistamiseksi
FI943316L (fi)	1994-07-12	Farmaseuttiset koostumukset, joissa on nifedipiiniä ja menetelmä sen valmistamiseksi
FI935465L (fi)	1994-06-08	Termoplastinen koostumus, menetelmä sen valmistamiseksi ja sen käyttö
FI942932L (fi)	1994-06-17	Farmaseuttinen koostumus ja menetelmä sen valmistamiseksi
FI944279L (fi)	1994-09-15	Suolatuote ja menetelmä sen valmistamiseksi
BR9200058A (pt)	1992-09-08	Composto e composicao farmaceutica
FI930326L (fi)	1994-07-28	Pinnoiteseos ja menetelmä sen valmistamiseksi
FI943383L (fi)	1994-08-31	Yhdiste FO-1289 ja menetelmä sen valmistamiseksi
FI930266L (fi)	1993-01-22	Vateriitti ja menetelmä sen valmistamiseksi
FI942499L (fi)	1994-07-27	Indolijohdannainen, menetelmä sen valmistamiseksi ja sen lääkekäyttö
FI944713L (fi)	1994-12-02	4-difenyylimetyylipiperidiinijohdannaisia ja menetelmä niiden valmistamiseksi
FI945975L (fi)	1995-06-22	Haarautuneella aminoryhmällä substituoituja tiatsoleja, menetelmiä niiden valmistamiseksi ja niitä sisältäviä farmaseuttisia koostumuksia
IT1239542B (it)	1993-11-05	Composizione farmaceutica comprendente piroxicam e procedimento per lasua preparazione